Case File
efta-efta00919975DOJ Data Set 9OtherFrom: Jeffrey Epstein <jeevacation®gmail.com>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00919975
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <jeevacation®gmail.com>
To: "Barrett, Paul S"
Subject: Re: Update
Date: Mon, 19 Sep 2011 14:19:51 +0000
do it
On Mon, Sep 19, 2011 at 10:08 AM, Barrett, Paul S <
Hi Jeffrey
> wrote:
We are long $I0MM worth of Indian Rupee and Singapore Dollar. Both currencies have sold off recently (SGD 5% and
INR 3%) since Sept Ist on liquidation and position squaring. I am worried that things will get worse in the near term
before recovering. So I think we switch from outright forwards into options.
Our recommendation is:
-
Unwind SGD forward and enter into a 1 month SGD call option. We are back to breakeven on this position and I do
not want to go into a loss. A 1 month SGD call will cost 1.2%. If it snaps back then we are long but if the unwind
continues we have no more downside exposure
-
Unwind INR Forward. We are now down $150K on the position since inception. INR has sold off 8% since early
Aug. I do think INR is cheap but remains vulnerable to worse macro news. We would recommend unwinding the
forward and buying a 47.00 Call on $20MM (twice what we have on via the forward) notional. Cost around 50bps.
Are you free to discuss?
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
EFTA00919975
212-622-2770 (w)
212-310-0108 (F)
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00919976
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.